Literature DB >> 11259576

The growth suppressor PML represses transcription by functionally and physically interacting with histone deacetylases.

W S Wu1, S Vallian, E Seto, W M Yang, D Edmondson, S Roth, K S Chang.   

Abstract

The growth suppressor promyelocytic leukemia protein (PML) is disrupted by the chromosomal translocation t(15;17) in acute promyelocytic leukemia (APL). PML plays a key role in multiple pathways of apoptosis and regulates cell cycle progression. The present study demonstrates that PML represses transcription by functionally and physically interacting with histone deacetylase (HDAC). Transcriptional repression mediated by PML can be inhibited by trichostatin A, a specific inhibitor of HDAC. PML coimmunoprecipitates a significant level of HDAC activity in several cell lines. PML is associated with HDAC in vivo and directly interacts with HDAC in vitro. The fusion protein PML-RARalpha encoded by the t(15;17) breakpoint interacts with HDAC poorly. PML interacts with all three isoforms of HDAC through specific domains, and its expression deacetylates histone H3 in vivo. Together, the results of our study show that PML modulates histone deacetylation and that loss of this function in APL alters chromatin remodeling and gene expression. This event may contribute to the development of leukemia.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11259576      PMCID: PMC86860          DOI: 10.1128/MCB.21.7.2259-2268.2001

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  77 in total

1.  Isolation and characterization of cDNAs corresponding to an additional member of the human histone deacetylase gene family.

Authors:  W M Yang; Y L Yao; J M Sun; J R Davie; E Seto
Journal:  J Biol Chem       Date:  1997-10-31       Impact factor: 5.157

2.  Molecular cloning of a new interferon-induced PML nuclear body-associated protein.

Authors:  C Gongora; G David; L Pintard; C Tissot; T D Hua; A Dejean; N Mechti
Journal:  J Biol Chem       Date:  1997-08-01       Impact factor: 5.157

3.  The transcriptional co-activator p/CIP binds CBP and mediates nuclear-receptor function.

Authors:  J Torchia; D W Rose; J Inostroza; Y Kamei; S Westin; C K Glass; M G Rosenfeld
Journal:  Nature       Date:  1997-06-12       Impact factor: 49.962

Review 4.  Histone acetylation in chromatin structure and transcription.

Authors:  M Grunstein
Journal:  Nature       Date:  1997-09-25       Impact factor: 49.962

5.  Localization of nascent RNA and CREB binding protein with the PML-containing nuclear body.

Authors:  V J LaMorte; J A Dyck; R L Ochs; R M Evans
Journal:  Proc Natl Acad Sci U S A       Date:  1998-04-28       Impact factor: 11.205

6.  Leukemia-associated retinoic acid receptor alpha fusion partners, PML and PLZF, heterodimerize and colocalize to nuclear bodies.

Authors:  M H Koken; A Reid; F Quignon; M K Chelbi-Alix; J M Davies; J H Kabarowski; J Zhu; S Dong; S Chen; Z Chen; C C Tan; J Licht; S Waxman; H de Thé; A Zelent
Journal:  Proc Natl Acad Sci U S A       Date:  1997-09-16       Impact factor: 11.205

7.  The major immediate-early proteins IE1 and IE2 of human cytomegalovirus colocalize with and disrupt PML-associated nuclear bodies at very early times in infected permissive cells.

Authors:  J H Ahn; G S Hayward
Journal:  J Virol       Date:  1997-06       Impact factor: 5.103

8.  Adenovirus-mediated expression of PML suppresses growth and tumorigenicity of prostate cancer cells.

Authors:  D He; Z M Mu; X Le; J T Hsieh; R C Pong; L W Chung; K S Chang
Journal:  Cancer Res       Date:  1997-05-15       Impact factor: 12.701

9.  Cell-cycle regulation of DNA damage-induced expression of the suppressor gene PML.

Authors:  J Y Chan; L Li; Y H Fan; Z M Mu; W W Zhang; K S Chang
Journal:  Biochem Biophys Res Commun       Date:  1997-11-26       Impact factor: 3.575

10.  Stable overexpression of PML alters regulation of cell cycle progression in HeLa cells.

Authors:  Z M Mu; X F Le; S Vallian; A B Glassman; K S Chang
Journal:  Carcinogenesis       Date:  1997-11       Impact factor: 4.944

View more
  48 in total

1.  PIASy, a nuclear matrix-associated SUMO E3 ligase, represses LEF1 activity by sequestration into nuclear bodies.

Authors:  S Sachdev; L Bruhn; H Sieber; A Pichler; F Melchior; R Grosschedl
Journal:  Genes Dev       Date:  2001-12-01       Impact factor: 11.361

2.  Histone sumoylation is associated with transcriptional repression.

Authors:  Yuzuru Shiio; Robert N Eisenman
Journal:  Proc Natl Acad Sci U S A       Date:  2003-10-24       Impact factor: 11.205

3.  SIRT1 stabilizes PML promoting its sumoylation.

Authors:  M Campagna; D Herranz; M A Garcia; L Marcos-Villar; J González-Santamaría; P Gallego; S Gutierrez; M Collado; M Serrano; M Esteban; C Rivas
Journal:  Cell Death Differ       Date:  2010-06-25       Impact factor: 15.828

4.  PML regulates PER2 nuclear localization and circadian function.

Authors:  Takao Miki; Zhixiang Xu; Misty Chen-Goodspeed; Mingguang Liu; Anita Van Oort-Jansen; Michael A Rea; Zhaoyang Zhao; Cheng Chi Lee; Kun-Sang Chang
Journal:  EMBO J       Date:  2012-01-24       Impact factor: 11.598

5.  Transcriptional regulation is affected by subnuclear targeting of reporter plasmids to PML nuclear bodies.

Authors:  Gregory J Block; Christopher H Eskiw; Graham Dellaire; David P Bazett-Jones
Journal:  Mol Cell Biol       Date:  2006-09-11       Impact factor: 4.272

6.  PHA-4/FoxA cooperates with TAM-1/TRIM to regulate cell fate restriction in the C. elegans foregut.

Authors:  Julie C Kiefer; Pliny A Smith; Susan E Mango
Journal:  Dev Biol       Date:  2006-12-02       Impact factor: 3.582

7.  Physical and functional interactions of histone deacetylase 3 with TFII-I family proteins and PIASxbeta.

Authors:  María Isabel Tussié-Luna; Dashzeveg Bayarsaihan; Edward Seto; Frank H Ruddle; Ananda L Roy
Journal:  Proc Natl Acad Sci U S A       Date:  2002-09-18       Impact factor: 11.205

8.  Human cytomegalovirus immediate-early 1 protein facilitates viral replication by antagonizing histone deacetylation.

Authors:  Michael Nevels; Christina Paulus; Thomas Shenk
Journal:  Proc Natl Acad Sci U S A       Date:  2004-11-30       Impact factor: 11.205

9.  Proteasome-independent disruption of PML oncogenic domains (PODs), but not covalent modification by SUMO-1, is required for human cytomegalovirus immediate-early protein IE1 to inhibit PML-mediated transcriptional repression.

Authors:  Y Xu; J H Ahn; M Cheng; C M apRhys; C J Chiou; J Zong; M J Matunis; G S Hayward
Journal:  J Virol       Date:  2001-11       Impact factor: 5.103

Review 10.  Changing nuclear landscape and unique PML structures during early epigenetic transitions of human embryonic stem cells.

Authors:  John T Butler; Lisa L Hall; Kelly P Smith; Jeanne B Lawrence
Journal:  J Cell Biochem       Date:  2009-07-01       Impact factor: 4.429

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.